Literature DB >> 18437275

Insight, cognitive dysfunction and symptomatology in schizophrenia.

Luciana C Monteiro1, Vanessa A Silva, Mario R Louzã.   

Abstract

Lack of insight is frequent in schizophrenia and usually influences negatively both patient's treatment and prognosis. This study aimed to investigate the relationship between insight, symptomatology and cognitive dysfunctions in schizophrenia using the PANSS five-factor model (modified from Gaag et al. in Schizophr Res 85:280-287, 2006). Forty patients diagnosed with chronic schizophrenia (DSM-IV) were evaluated with the scale to assess unawareness of mental disorder (SUMD), the PANSS and a neuropsychological battery. Spearman correlation and linear regression analyses were performed to investigate the relationship between clinical, neurocognitive and insight measures. The SUMD current and past awareness of symptoms score showed a correlation with WCST indices (correct answers and non-persevering errors). The negative and disorganization factor of the PANSS showed a positive correlation with current and past awareness of symptoms. However, when submitted to a linear regression model only the disorganization factor emerged as significant contributor for insight. Considering that the core items of the "disorganization factor" of the PANSS are related to cognition (e.g., poor attention, difficult in abstract thinking), insight is associated cognitive symptoms although no direct relationship between insight and neuropsychological tests was observed.

Entities:  

Mesh:

Year:  2008        PMID: 18437275     DOI: 10.1007/s00406-008-0809-8

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  29 in total

1.  The five-factor model of the Positive and Negative Syndrome Scale II: a ten-fold cross-validation of a revised model.

Authors:  Mark van der Gaag; Tonko Hoffman; Mila Remijsen; Ron Hijman; Lieuwe de Haan; Berno van Meijel; Peter N van Harten; Lucia Valmaggia; Marc de Hert; Anke Cuijpers; Durk Wiersma
Journal:  Schizophr Res       Date:  2006-05-26       Impact factor: 4.939

Review 2.  Insight in schizophrenia: a meta-analysis.

Authors:  Alisa R Mintz; Keith S Dobson; David M Romney
Journal:  Schizophr Res       Date:  2003-05-01       Impact factor: 4.939

3.  Translation, adaptation and reliability study of the Scale to Assess Unawareness of Mental Disorder--SUMD.

Authors:  Nina Fiss; Ana Cristina Chaves
Journal:  Braz J Psychiatry       Date:  2005-06-13       Impact factor: 2.697

Review 4.  Psychopathologic domains and insight in schizophrenia.

Authors:  X F Amador; J M Gorman
Journal:  Psychiatr Clin North Am       Date:  1998-03

5.  A meta-analytic review of Wisconsin Card Sort studies in schizophrenia: general intellectual deficit in disguise?

Authors:  K R Laws
Journal:  Cogn Neuropsychiatry       Date:  1999-02       Impact factor: 1.871

6.  Insight, symptoms, and neurocognition in schizophrenia and schizoaffective disorder.

Authors:  T E Smith; J W Hull; L M Israel; D F Willson
Journal:  Schizophr Bull       Date:  2000       Impact factor: 9.306

7.  Insight and cognitive impairment in schizophrenia. Performance on repeated administrations of the Wisconsin Card Sorting Test.

Authors:  P Lysaker; M Bell
Journal:  J Nerv Ment Dis       Date:  1994-11       Impact factor: 2.254

8.  The relationship between insight and symptoms in schizophrenia.

Authors:  Serge Sevy; Kay Nathanson; Hema Visweswaraiah; Xavier Amador
Journal:  Compr Psychiatry       Date:  2004 Jan-Feb       Impact factor: 3.735

Review 9.  Chlorpromazine equivalent doses for the newer atypical antipsychotics.

Authors:  Scott W Woods
Journal:  J Clin Psychiatry       Date:  2003-06       Impact factor: 4.384

10.  Insight dimensions and cognitive function in psychosis: a longitudinal study.

Authors:  Manuel J Cuesta; Victor Peralta; Amalia Zarzuela; Maria Zandio
Journal:  BMC Psychiatry       Date:  2006-05-31       Impact factor: 3.630

View more
  15 in total

1.  Examining a progressive model of self-stigma and its impact on people with serious mental illness.

Authors:  Patrick W Corrigan; Jennifer Rafacz; Nicolas Rüsch
Journal:  Psychiatry Res       Date:  2011-06-28       Impact factor: 3.222

2.  Searching for a consensus five-factor model of the Positive and Negative Syndrome Scale for schizophrenia.

Authors:  R S Wallwork; R Fortgang; R Hashimoto; D R Weinberger; D Dickinson
Journal:  Schizophr Res       Date:  2012-02-21       Impact factor: 4.939

3.  Neurocognitive insight and objective cognitive functioning in schizophrenia.

Authors:  Cynthia Z Burton; Philip D Harvey; Thomas L Patterson; Elizabeth W Twamley
Journal:  Schizophr Res       Date:  2016-01-23       Impact factor: 4.939

Review 4.  Systematic review reveals heterogeneity in the use of the Scale to Assess Unawareness of Mental Disorder (SUMD).

Authors:  Rémy Dumas; Karine Baumstarck; Pierre Michel; Christophe Lançon; Pascal Auquier; Laurent Boyer
Journal:  Curr Psychiatry Rep       Date:  2013-06       Impact factor: 5.285

5.  The relationship between clinical insight and cognitive and affective empathy in schizophrenia.

Authors:  Mia Atoui; Fatima El Jamil; Joseph El Khoury; Mark Doumit; Nathalie Syriani; Munir Khani; Ziad Nahas
Journal:  Schizophr Res Cogn       Date:  2018-05-14

6.  The Relationship between Attention/Vigilance and Symptom Severity in Schizophrenic Patients.

Authors:  Atefeh Ghanbari Jolfaei; Pegah Moshki; Mania Asgharpour; Hamid Moshki
Journal:  Iran J Psychiatry       Date:  2012

Review 7.  Insight in schizophrenia: relationship to positive, negative and neurocognitive dimensions.

Authors:  Boban Joseph; Janardhanan C Narayanaswamy; Ganesan Venkatasubramanian
Journal:  Indian J Psychol Med       Date:  2015 Jan-Mar

8.  Prominent clinical dimension, duration of illness and treatment response in schizophrenia: a naturalistic study.

Authors:  Massimiliano Buoli; Alice Caldiroli; Gabriele Panza; Alfredo Carlo Altamura
Journal:  Psychiatry Investig       Date:  2012-11-14       Impact factor: 2.505

9.  Cognitive training for schizophrenia in developing countries: a pilot trial in Brazil.

Authors:  Livia M M Pontes; Camila B Martins; Isabel C Napolitano; Juliana R Fonseca; Graça M R Oliveira; Sandra M K Iso; Anny K P M Menezes; Adriana D B Vizzotto; Elaine S di Sarno; Hélio Elkis
Journal:  Schizophr Res Treatment       Date:  2013-10-30

10.  Relationship between negative symptoms and neurocognitive functions in adolescent and adult patients with first-episode schizophrenia.

Authors:  Manli Huang; Yi Huang; Liang Yu; Jianbo Hu; Jinkai Chen; Pingbo Jin; Weijuan Xu; Ning Wei; Shaohua Hu; Hongli Qi; Yi Xu
Journal:  BMC Psychiatry       Date:  2016-10-06       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.